Medical Marijuana Use in HIV+ Patients: Probability Survey

HIV Positive Clinical Trial

— MMS  

Official title:

Behavioral Economic Analysis of Medical Marijuana Use in HIV+ Patients: Probability Survey

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01536912
• Other study ID #: MMS-1
• Secondary ID: R01DA032678
• Status: Completed
• Phase: N/A
• First received: February 16, 2012
• Last updated: July 29, 2015
• Start date: February 2012
• Est. completion date: December 2014

Study information

• Verified date: July 2015
• Source: Wayne State University
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal GovernmentUnited States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

More scientific information is needed about medical marijuana use among HIV positive patients. There is conflicting information about the use of marijuana, use of medical marijuana, and the associations between them and health status/health risk behaviors/health care utilization. In addition, it is not clear whether patients who participate in prospective clinical studies differ from participants who do not participate; if there are differences between those two groups, then this would limit generalizability of knowledge about these issues.

The goal of this project is to describe the use of marijuana among HIV positive patients and its association with health status/health risk behaviors/health care utilization.

Description:

Participants will answer questions about marijuana, medical marijuana, and other drug use. We will also ask about health and steps participants take to keep healthy. The study will take up to one hour to complete.

Participants will also be asked to sign a release of information form. This form would allow us to look at medical records at the HIV clinic.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 218
• Est. completion date: December 2014
• Est. primary completion date: December 2014
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 70 Years

Eligibility

Inclusion Criteria:

• Patients in the HIV clinic

• HIV positive

Exclusion Criteria:

• Lack of english

Study Design

Observational Model: Case-Only

Related Conditions & MeSH terms

• HIV Positive
• HIV Seropositivity

Locations

Country	Name	City	State
United States	Wayne State University (HIV clinic, Tolan Park Medical Building)	Detroit	Michigan

Sponsors (2)

Lead Sponsor	Collaborator
Wayne State University	National Institute on Drug Abuse (NIDA)

Country where clinical trial is conducted

United States,